Practice
Featured experience
Cerebras Systems $6.4 billion IPO
We advised the underwriters on the IPO
Alphabet $20 billion notes offering
We advised the global coordinators and book-running managers on the offering
Arxis $1.3 billion IPO
We advised Arxis on its IPO
Novartis $11 billion notes offering
We advised Novartis on the investment-grade debt offering
Thyme Companies $125 million Series E financing
We advised Morgan Health as lead investor on the financing
NTT Finance concurrent $5.5 billion, €3.85 billion and £400 million debt offerings
We advised the initial purchasers on the senior notes offerings
BBVA $2.3 billion senior non-preferred notes offering
We advised BBVA on the offering
Oesterreichische Kontrollbank $1 billion notes offering
We advised the underwriters on the offering
U.S. Steel $1.2 billion guaranteed senior notes offering
We advised the joint bookrunners on the offering
Corvex $33 million private placement
We advised Corvex on the PIPE
Mech-Mind HK$2.71 billion Hong Kong IPO
We advised Mech-Mind on its IPO and HKEX listing
Moderna $3 billion convertible notes offering and capped call transactions
We advised the initial purchasers on the offering
Jazz Pharmaceuticals $1.25 billion exchangeable senior notes offering
We advised the initial purchasers on the offering
JATT III Acquisition Corp $69 million SPAC IPO
We advised the sole bookrunning manager on the IPO